{
    "clinical_study": {
        "@rank": "35358", 
        "brief_summary": {
            "textblock": "To perform preliminary clinical testing of diethylhomospermine (DEHSPM), a polyamine\n      analogue, for refractory AIDS-related diarrhea.\n\n      Possibly, DEHSPM will reduce stool volume and frequency in patients with refractory\n      AIDS-related diarrhea."
        }, 
        "brief_title": "Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea", 
        "condition": [
            "Diarrhea", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Diarrhea"
            ]
        }, 
        "detailed_description": {
            "textblock": "Possibly, DEHSPM will reduce stool volume and frequency in patients with refractory\n      AIDS-related diarrhea.\n\n      Patients are initially hydrated for 24 hours, followed by a 3-day baseline period. They then\n      receive intravenous infusions of DEHSPM three times per day for 3 days, followed by\n      observation for 3 days."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  ARC or AIDS by CDC criteria.\n\n          -  Uncontrolled diarrhea unresponsive to high-dose, nonspecific antidiarrheal therapy.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Known idiopathic ulcerative colitis or Crohn colitis.\n\n          -  Acute stool-culture-positive bacterial colitis.\n\n          -  Acute amoebic colitis.\n\n          -  Pseudomembranous colitis with Clostridium difficile toxin positivity.\n\n          -  Short-gut syndrome.\n\n          -  Chronic pancreatitis.\n\n          -  Ischemic bowel disease.\n\n          -  Enteroenteric fistulae.\n\n          -  Other gastrointestinal tract disorders known to cause diarrhea.\n\n          -  Underlying evidence of immunosuppression other than that related to HIV infection.\n\n          -  Unable or unwilling to have subcutaneous injections.\n\n          -  Clinically significant CNS, hepatic, or renal disease.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Other experimental antidiarrheal drugs.\n\n          -  Antibiotic therapy.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Other experimental drugs within 1 month prior to study entry.\n\n        Required:\n\n          -  At least 2 weeks of prior high-dose, nonspecific antidiarrheal therapy (i.e.,\n             loperamide, diphenoxylate hydrochloride-atropine sulfate, or opiates) at maximally\n             tolerable doses."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002121", 
            "org_study_id": "223A"
        }, 
        "intervention": {
            "intervention_name": "Diethylhomospermine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "N(1),N(14)-bis(ethyl)homospermine"
        }, 
        "keyword": [
            "Antidiarrheals", 
            "Diarrhea", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "N(1),N(14)-bis(ethyl)homospermine"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Gainesville", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32608"
                }, 
                "name": "Gainesville Veterans Administration Med Ctr"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Diethylhomospermine (DEHSPM) for Refractory AIDS-Related Diarrhea", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002121"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "VA Medical Center-Gainesville", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 1996"
    }, 
    "geocoordinates": {
        "Gainesville Veterans Administration Med Ctr": "29.652 -82.325"
    }
}